These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15371634)

  • 21. Increased infant human immunodeficiency virus-type one free survival at one year of age in sub-saharan Africa with maternal use of highly active antiretroviral therapy during breast-feeding.
    Marazzi MC; Nielsen-Saines K; Buonomo E; Scarcella P; Germano P; Majid NA; Zimba I; Ceffa S; Palombi L
    Pediatr Infect Dis J; 2009 Jun; 28(6):483-7. PubMed ID: 19483516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial.
    Sibiude J; Le Chenadec J; Bonnet D; Tubiana R; Faye A; Dollfus C; Mandelbrot L; Delmas S; Lelong N; Khoshnood B; Warszawski J; Blanche S;
    Clin Infect Dis; 2015 Jul; 61(2):270-80. PubMed ID: 25838291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of HIV-infected pregnant women: prevention of virus transmission and adverse effects in mother and child].
    Boer K; Nellen JF; Kreyenbroek ME; Godfried MH
    Ned Tijdschr Geneeskd; 2009; 153():B410. PubMed ID: 19785876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perinatal outcomes, mitochondrial toxicity and apoptosis in HIV-treated pregnant women and in-utero-exposed newborn.
    Hernàndez S; Morén C; López M; Coll O; Cardellach F; Gratacós E; Miró O; Garrabou G
    AIDS; 2012 Feb; 26(4):419-28. PubMed ID: 22156962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy.
    Alimenti A; Burdge DR; Ogilvie GS; Money DM; Forbes JC
    Pediatr Infect Dis J; 2003 Sep; 22(9):782-9. PubMed ID: 14506368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased rate of prematurity associated with antenatal antiretroviral therapy in a German/Austrian cohort of HIV-1-infected women.
    Grosch-Woerner I; Puch K; Maier RF; Niehues T; Notheis G; Patel D; Casteleyn S; Feiterna-Sperling C; Groeger S; Zaknun D;
    HIV Med; 2008 Jan; 9(1):6-13. PubMed ID: 18199167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of highly active antiretroviral treatment (HAART) during pregnancy on pregnancy outcomes: experiences from a PMTCT program in western India.
    Darak S; Darak T; Kulkarni S; Kulkarni V; Parchure R; Hutter I; Janssen F
    AIDS Patient Care STDS; 2013 Mar; 27(3):163-70. PubMed ID: 23477457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left ventricular diastolic dysfunction in HIV-uninfected infants exposed in utero to antiretroviral therapy.
    Lipshultz SE; Sasaki N; Thompson B; Eidem BW; Cheng I; Colan SD; O'Brien SE; Amdani S; Shearer WT; Orav EJ; Miller TL; Wilkinson JD
    AIDS; 2020 Mar; 34(4):529-537. PubMed ID: 31764073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Highly active antiretroviral therapy (HAART) in HIV-positive pregnant women in the Netherlands, 1997-2003: safe, effective and with few side effects].
    Tempelman C; Timmermans S; Godfried MH; Dieleman JP; Boer K; van der Ende ME
    Ned Tijdschr Geneeskd; 2004 Oct; 148(41):2021-5. PubMed ID: 15553999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In utero exposure to tenofovir disoproxil fumarate does not impair growth and bone health in HIV-uninfected children born to HIV-infected mothers.
    Viganò A; Mora S; Giacomet V; Stucchi S; Manfredini V; Gabiano C; Salvini F; Cellini M; Tamburrini E; Puzzovio M; Zuccotti GV
    Antivir Ther; 2011; 16(8):1259-66. PubMed ID: 22155907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematological Indices at Birth of Infants of HIV-Positive Mothers Participating in a Prevention of Mother-to-Child Transmission Program.
    Obumneme-Anyim I; Ibeziako N; Emodi I; Ikefuna A; Oguonu T
    J Trop Pediatr; 2016 Feb; 62(1):3-9. PubMed ID: 26411560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
    AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies against pneumococcal capsular polysaccharide in Malawian HIV-positive mothers and their HIV-exposed uninfected children.
    Baroncelli S; Galluzzo CM; Mancinelli S; Andreotti M; Jere H; Amici R; Marazzi MC; Vella S; Palombi L; Giuliano M
    Infect Dis (Lond); 2016 Apr; 48(4):317-321. PubMed ID: 26609569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug safety during pregnancy and in infants. Lack of mortality related to mitochondrial dysfunction among perinatally HIV-exposed children in pediatric HIV surveillance.
    Lindegren ML; Rhodes P; Gordon L; Fleming P; ;
    Ann N Y Acad Sci; 2000 Nov; 918():222-35. PubMed ID: 11131709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of evidence of mitochondrial dysfunction in the offspring of HIV-infected women. Retrospective review of perinatal exposure to antiretroviral drugs in the Perinatal AIDS Collaborative Transmission Study.
    Bulterys M; Nesheim S; Abrams EJ; Palumbo P; Farley J; Lampe M; Fowler MG;
    Ann N Y Acad Sci; 2000 Nov; 918():212-21. PubMed ID: 11131707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.
    Senise JF; Castelo A; Martínez M
    AIDS Rev; 2011; 13(4):198-213. PubMed ID: 21975356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
    Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
    J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of in-utero antiretroviral exposure: neurologic outcomes in children who are HIV-exposed but uninfected.
    Crowell CS; Williams PL; Yildirim C; Van Dyke RB; Smith R; Chadwick EG; Seage GR; Diperna A; Hazra R;
    AIDS; 2020 Jul; 34(9):1377-1387. PubMed ID: 32310900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.